These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3805873)

  • 41. Failure of collagen to activate factor XII.
    Zacharski LR; Rosenstein R
    Thromb Res; 1975 Dec; 7(6):929-33. PubMed ID: 1198559
    [No Abstract]   [Full Text] [Related]  

  • 42. [Ultralow doses of oxytocin change blood coagulation in humans].
    Uryvaev IuV; Petrov GA
    Dokl Akad Nauk; 1993 Sep; 332(1):115-7. PubMed ID: 8220208
    [No Abstract]   [Full Text] [Related]  

  • 43. [Several integral indices of erythrocyte preservation after contact exocellular cryoprotectors].
    Shrago MI; Timchenko VG; Bredikhina LP; Lubianyĭ VG
    Fiziol Zh; 1978; 24(3):387-91. PubMed ID: 658500
    [No Abstract]   [Full Text] [Related]  

  • 44. Further comments on the failure of collagen to activate factor XIII.
    Zacharski LR; Rosenstein R
    Thromb Res; 1977 May; 10(5):771-2. PubMed ID: 882963
    [No Abstract]   [Full Text] [Related]  

  • 45. GP crisis requires more than just technology to fix it.
    Hodes S; Hussain S; Salisbury H; Welch E; Whitaker P
    BMJ; 2022 Jul; 378():o1670. PubMed ID: 35803610
    [No Abstract]   [Full Text] [Related]  

  • 46. The rare complication of vascular malformations of the limb after sclerotherapy: a report of 3 cases and brief literature review.
    Sun N; Liu R; Cheng G; Wu P; Yu F; Qing L; Zeng L; Pang X; Pan D; Xiao Y; Khan UZ; Tang J
    BMC Pediatr; 2023 Apr; 23(1):202. PubMed ID: 37106458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children - A retrospective cohort study from a single tertiary medical center.
    Hou F; Chen J; Xia M; Ding K; Zeng Q; Liu W
    Medicine (Baltimore); 2020 Feb; 99(9):e18839. PubMed ID: 32118707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Step-by-Step Practical Approach to Imaging Diagnosis and Interventional Radiologic Therapy in Vascular Malformations.
    Legiehn GM; Heran MK
    Semin Intervent Radiol; 2010 Jun; 27(2):209-31. PubMed ID: 21629410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The possible risk of lower-limb sclerotherapy causing an extended hypercoagulable state.
    Ariyoshi H; Kambayashi J; Tominaga S; Hatanaka T
    Surg Today; 1996; 26(5):323-7. PubMed ID: 8726616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy.
    Musso R; Longo A; Triolo A; Giustolisi R; Cacciola RR; Cacciola E; Vecchio R; Russo A; Magnano A
    Gastrointest Endosc; 1987 Oct; 33(5):400-2. PubMed ID: 3678776
    [No Abstract]   [Full Text] [Related]  

  • 51. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
    Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
    J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel roles for factor XII-driven plasma contact activation system.
    Müller F; Renné T
    Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: possible additional mechanism of adverse reaction during sclerotherapy.
    Cacciola E; Giustolisi R; Musso R; Vecchio R; Longo A; Triolo A; Cacciola RR
    J Lab Clin Med; 1987 Feb; 109(2):225-6. PubMed ID: 3805873
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.